首页 > 最新文献

NMC Case Report Journal最新文献

英文 中文
Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report. 差异靶点多重刺激脊髓对遗传性神经病伴压迫性麻痹顽固性疼痛的疗效:1例报告。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2023-0023
Takafumi Tanei, Yusuke Nishimura, Yoshitaka Nagashima, Motonori Ishii, Tomoya Nishii, Nobuhisa Fukaya, Takashi Abe, Hiroyuki Kato, Satoshi Maesawa, Ryuta Saito

Hereditary neuropathy with liability to pressure palsies is an extremely rare genetic disorder; it is an autosomal dominant disorder with a high incidence of neuropathic and/or musculoskeletal pain. A case of achieving pain relief by spinal cord stimulation using differential target multiplexed stimulation for a 44-year-old female patient with hereditary neuropathy with liability to pressure palsies who was experiencing severe pain in her back, face, and all four limbs is presented. In her early teens, the initial symptoms were numbness and weakness of a limb after movement, which improved spontaneously. Transient pain in her back followed by systemic and persistent muscle weakness and pain developed. Deletion of the gene for peripheral myelin protein 22 was detected by peripheral nerve biopsy. The diagnosis of hereditary neuropathy with liability to pressure palsies was made in her early thirties. A spinal cord stimulation trial was performed because her severe pain continued despite administering many medications. Therefore, two spinal cord stimulation systems were implanted at the C3-5 and Th8-9 levels by two procedures. Pain in her back, arms, and legs decreased from 8 to 1, 5 to 1, and 6 to 2 on the numerical rating scale, respectively. Furthermore, opioid usage was tapered. The pain of hereditary neuropathy with liability to pressure palsies has a complicated pathogenesis and is resistant to pharmacological treatment. Spinal cord stimulation using differential target multiplexed stimulation may be a viable treatment option.

遗传性神经病变与压力性麻痹是一种极其罕见的遗传疾病;它是一种常染色体显性遗传病,发病率高,伴有神经性和/或肌肉骨骼疼痛。本文报告一例44岁女性遗传性神经病伴压迫性麻痹患者,背部、面部及四肢均出现剧烈疼痛,采用差异靶点多路脊髓刺激实现疼痛缓解。在她十几岁的时候,最初的症状是运动后肢体麻木和无力,随后自发改善。她的背部出现一过性疼痛,随后出现全身和持续性肌肉无力和疼痛。外周神经活检检测外周髓鞘蛋白22基因缺失。她在30岁出头时被诊断为遗传性神经病变,易患压力性麻痹。尽管服用了许多药物,但她的剧烈疼痛仍在继续,因此进行了脊髓刺激试验。因此,通过两个步骤在C3-5和Th8-9水平植入两个脊髓刺激系统。她的背部、手臂和腿部疼痛分别从8分降至1分、5分降至1分、6分降至2分。此外,阿片类药物的使用逐渐减少。遗传性神经病变伴压迫性麻痹的疼痛,其发病机制复杂,对药物治疗有抗性。采用不同靶点多路刺激的脊髓刺激可能是一种可行的治疗选择。
{"title":"Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report.","authors":"Takafumi Tanei,&nbsp;Yusuke Nishimura,&nbsp;Yoshitaka Nagashima,&nbsp;Motonori Ishii,&nbsp;Tomoya Nishii,&nbsp;Nobuhisa Fukaya,&nbsp;Takashi Abe,&nbsp;Hiroyuki Kato,&nbsp;Satoshi Maesawa,&nbsp;Ryuta Saito","doi":"10.2176/jns-nmc.2023-0023","DOIUrl":"https://doi.org/10.2176/jns-nmc.2023-0023","url":null,"abstract":"<p><p>Hereditary neuropathy with liability to pressure palsies is an extremely rare genetic disorder; it is an autosomal dominant disorder with a high incidence of neuropathic and/or musculoskeletal pain. A case of achieving pain relief by spinal cord stimulation using differential target multiplexed stimulation for a 44-year-old female patient with hereditary neuropathy with liability to pressure palsies who was experiencing severe pain in her back, face, and all four limbs is presented. In her early teens, the initial symptoms were numbness and weakness of a limb after movement, which improved spontaneously. Transient pain in her back followed by systemic and persistent muscle weakness and pain developed. Deletion of the gene for peripheral myelin protein 22 was detected by peripheral nerve biopsy. The diagnosis of hereditary neuropathy with liability to pressure palsies was made in her early thirties. A spinal cord stimulation trial was performed because her severe pain continued despite administering many medications. Therefore, two spinal cord stimulation systems were implanted at the C3-5 and Th8-9 levels by two procedures. Pain in her back, arms, and legs decreased from 8 to 1, 5 to 1, and 6 to 2 on the numerical rating scale, respectively. Furthermore, opioid usage was tapered. The pain of hereditary neuropathy with liability to pressure palsies has a complicated pathogenesis and is resistant to pharmacological treatment. Spinal cord stimulation using differential target multiplexed stimulation may be a viable treatment option.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"203-208"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/46/2188-4226-10-0203.PMC10396390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9930313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Case of Tracheo-innominate Artery Fistula after Tracheostomy Successfully Treated with a Covered Stent. 覆盖支架成功治疗气管造口术后气管无名动脉瘘1例。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0250
Takayuki Kakimoto, Satoshi Murai, Noboru Kusaka, Fukiko Baba, Yohei Inoue, Hayato Miyake, Masato Kawakami, Yukei Shinji, Hisakazu Itami, Shinji Otsuka, Tsukasa Nishiura, Kenji Kawamoto, Tsuyoshi Yamamoto, Nobuhiko Kimura, Kotaro Ogihara

A 78-year-old man underwent a tracheostomy after embolization for a dural arteriovenous fistula. Seventy days after tracheostomy, arterial bleeding appeared through the tracheal stoma. The bleeding stopped spontaneously. However, two days later, arterial bleeding reappeared, and he was diagnosed with a tracheo-innominate artery fistula (TIF). He then underwent urgent endovascular covered stent placement. After the procedure, there was no bleeding. TIF can be a fatal complication after tracheostomy and it is generally treated with open chest surgery. However, a successful endovascular treatment for TIF has recently been reported and may yield better results.

一位78岁的男性在硬脑膜动静脉瘘栓塞后接受了气管切开术。气管造口术后70天出现动脉性出血。出血自然止住了。然而,两天后,动脉出血再次出现,并被诊断为气管无名动脉瘘(TIF)。随后他接受了紧急血管内覆盖支架置入术。手术后,没有出血。TIF可能是气管切开术后的致命并发症,通常通过开胸手术治疗。然而,最近报道了一种成功的血管内治疗TIF的方法,可能会产生更好的结果。
{"title":"A Case of Tracheo-innominate Artery Fistula after Tracheostomy Successfully Treated with a Covered Stent.","authors":"Takayuki Kakimoto,&nbsp;Satoshi Murai,&nbsp;Noboru Kusaka,&nbsp;Fukiko Baba,&nbsp;Yohei Inoue,&nbsp;Hayato Miyake,&nbsp;Masato Kawakami,&nbsp;Yukei Shinji,&nbsp;Hisakazu Itami,&nbsp;Shinji Otsuka,&nbsp;Tsukasa Nishiura,&nbsp;Kenji Kawamoto,&nbsp;Tsuyoshi Yamamoto,&nbsp;Nobuhiko Kimura,&nbsp;Kotaro Ogihara","doi":"10.2176/jns-nmc.2022-0250","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0250","url":null,"abstract":"<p><p>A 78-year-old man underwent a tracheostomy after embolization for a dural arteriovenous fistula. Seventy days after tracheostomy, arterial bleeding appeared through the tracheal stoma. The bleeding stopped spontaneously. However, two days later, arterial bleeding reappeared, and he was diagnosed with a tracheo-innominate artery fistula (TIF). He then underwent urgent endovascular covered stent placement. After the procedure, there was no bleeding. TIF can be a fatal complication after tracheostomy and it is generally treated with open chest surgery. However, a successful endovascular treatment for TIF has recently been reported and may yield better results.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"21-25"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/9e/2188-4226-10-0021.PMC10017121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9145749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occult Germinoma of the Intramedullary Spinal Cord: A Case Report. 髓内脊髓隐匿性生殖细胞瘤1例报告。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0346
Takumi Hoshimaru, Fugen Takagi, Yuichiro Tsuji, Ryokichi Yagi, Ryo Hiramatsu, Masahiro Kameda, Naosuke Nonoguchi, Motomasa Furuse, Shinji Kawabata, Toshihiro Takami, Masahiko Wanibuchi

Primary germ cell tumors of the central nervous system (CNS) typically occur in the neurohypophysis, hypothalamus, or pineal gland and rarely in the spinal cord. We report a case of a spinal intramedullary tumor, which was first detected on magnetic resonance imaging (MRI) 41 months after the initial symptoms, with a verified pathological diagnosis of germinoma. The initial symptom was an abnormal sensation in the left plantar region that gradually worsened, resulting in severe sensory disturbance, difficulty in standing, and even bladder rectal disturbance. Repeated MRI after the onset failed to provide an imaging diagnosis. The MRI was performed 41 months after the onset and revealed a previously undiagnosed, contrast-enhancing spinal intramedullary neoplastic lesion at the Th11-12 level. Gross total resection of the tumor was successfully performed, and the pathology confirmed the diagnosis of pure germinoma. Postoperative chemotherapy, followed by local radiation, was successfully administered. Among primary germinomas of the CNS, occult germinoma that lacks imaging findings suggestive of tumors in the early stages of onset and becomes apparent over time is often reported as a primary neurohypophyseal germinoma, particularly in adolescents presenting with diabetes insipidus. In the present case, the lesion appeared to correspond to a primary occult germinoma of the intramedullary spinal cord.

中枢神经系统(CNS)的原发性生殖细胞瘤通常发生在神经垂体、下丘脑或松果体,很少发生在脊髓。我们报告一例脊髓髓内肿瘤,在最初症状41个月后首次在磁共振成像(MRI)上检测到,病理诊断为生殖细胞瘤。最初症状为左足底区感觉异常,逐渐加重,导致严重的感觉障碍,站立困难,甚至膀胱直肠紊乱。发病后反复MRI未能提供影像学诊断。在发病41个月后进行MRI检查,发现Th11-12水平有一个未确诊的脊髓髓内肿瘤病变。肿瘤全切除成功,病理证实为纯粹的生殖细胞瘤。术后化疗,随后局部放疗,成功实施。在中枢神经系统的原发性生殖细胞瘤中,隐匿性生殖细胞瘤在发病早期缺乏肿瘤的影像学表现,随着时间的推移变得明显,通常被报道为原发性神经垂体性生殖细胞瘤,特别是在以尿崩症为表现的青少年中。在本病例中,病变似乎对应于髓内脊髓的原发性隐匿性生殖细胞瘤。
{"title":"Occult Germinoma of the Intramedullary Spinal Cord: A Case Report.","authors":"Takumi Hoshimaru,&nbsp;Fugen Takagi,&nbsp;Yuichiro Tsuji,&nbsp;Ryokichi Yagi,&nbsp;Ryo Hiramatsu,&nbsp;Masahiro Kameda,&nbsp;Naosuke Nonoguchi,&nbsp;Motomasa Furuse,&nbsp;Shinji Kawabata,&nbsp;Toshihiro Takami,&nbsp;Masahiko Wanibuchi","doi":"10.2176/jns-nmc.2022-0346","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0346","url":null,"abstract":"<p><p>Primary germ cell tumors of the central nervous system (CNS) typically occur in the neurohypophysis, hypothalamus, or pineal gland and rarely in the spinal cord. We report a case of a spinal intramedullary tumor, which was first detected on magnetic resonance imaging (MRI) 41 months after the initial symptoms, with a verified pathological diagnosis of germinoma. The initial symptom was an abnormal sensation in the left plantar region that gradually worsened, resulting in severe sensory disturbance, difficulty in standing, and even bladder rectal disturbance. Repeated MRI after the onset failed to provide an imaging diagnosis. The MRI was performed 41 months after the onset and revealed a previously undiagnosed, contrast-enhancing spinal intramedullary neoplastic lesion at the Th11-12 level. Gross total resection of the tumor was successfully performed, and the pathology confirmed the diagnosis of pure germinoma. Postoperative chemotherapy, followed by local radiation, was successfully administered. Among primary germinomas of the CNS, occult germinoma that lacks imaging findings suggestive of tumors in the early stages of onset and becomes apparent over time is often reported as a primary neurohypophyseal germinoma, particularly in adolescents presenting with diabetes insipidus. In the present case, the lesion appeared to correspond to a primary occult germinoma of the intramedullary spinal cord.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"27-32"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/9d/2188-4226-10-0027.PMC10017122.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9145752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enterprise Treatment for Recurrent Basilar Tip Aneurysm after PulseRider-assisted Coil Embolization: A Case Report. 脉冲星辅助线圈栓塞后复发基底动脉瘤的企业治疗1例。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0316
Takahiro Yokoyama, Tatsuya Ishikawa, Yosuke Moteki, Takayuki Funatsu, Koji Yamaguchi, Seiichiro Eguchi, Hayato Yamahata, Buntou Ro, Takakazu Kawamata

PulseRider (Cerenovus, Irvine, CA, USA) is a relatively novel device used for the treatment of wide-neck aneurysms with a coil-assisted effect. However, treatment options for recurrent aneurysms after PulseRider-assisted coil embolization remain controversial. Here we report a case of recurrent basilar tip aneurysm (BTA) treated with Enterprise 2 after PulseRider-assisted coil embolization. A woman in her 70s underwent coil embolization for a subarachnoid hemorrhage with ruptured BTA 16 years ago. Recurrence was detected at 6-year follow-up, and an additional coil embolization was performed. Nevertheless, gradual recurrence still occurred, and PulseRider-assisted coil embolization was performed without any complications 9 years after the second treatment. However, recurrence was detected once more at 6-month follow-up. Thus, stent-assisted coil embolization using Enterprise 2 (Cerenovus) through PulseRider was selected for angular remodeling. Enterprise 2 was deployed between the right P2 segment of the posterior cerebral artery (PCA) and basilar artery (BA) after an effective coil embolization, which achieved effective angular remodeling between the right PCA and BA. The patient's postoperative course was uneventful, and no recanalization was detected after half a year. Although PulseRider is effective for wide-neck aneurysm treatment, recurrence remains a possibility. Additional treatment using Enterprise 2 is safe and effective with the expectation of angular remodeling.

PulseRider (Cerenovus, Irvine, CA, USA)是一种相对新颖的装置,用于治疗具有线圈辅助作用的宽颈动脉瘤。然而,pulserider辅助线圈栓塞后复发动脉瘤的治疗选择仍然存在争议。在此,我们报告一例复发的基底动脉瘤(BTA)在pulseride辅助线圈栓塞后用Enterprise 2治疗。16年前,一名70多岁的妇女因蛛网膜下腔出血和BTA破裂接受了线圈栓塞术。在6年随访中发现复发,并进行了额外的线圈栓塞。然而,逐渐复发仍然发生,第二次治疗9年后,pulserider辅助线圈栓塞无任何并发症。然而,在6个月的随访中再次发现复发。因此,支架辅助线圈栓塞采用Enterprise 2 (Cerenovus)通过PulseRider进行角度重构。Enterprise 2在有效的线圈栓塞后被部署在大脑后动脉(PCA)右侧P2段与基底动脉(BA)之间,实现了右侧PCA与BA之间有效的角度重塑。患者术后过程平稳,半年后未发现再通。虽然PulseRider对宽颈动脉瘤治疗有效,但仍有复发的可能。使用Enterprise 2的附加治疗是安全有效的,并期望角重塑。
{"title":"Enterprise Treatment for Recurrent Basilar Tip Aneurysm after PulseRider-assisted Coil Embolization: A Case Report.","authors":"Takahiro Yokoyama,&nbsp;Tatsuya Ishikawa,&nbsp;Yosuke Moteki,&nbsp;Takayuki Funatsu,&nbsp;Koji Yamaguchi,&nbsp;Seiichiro Eguchi,&nbsp;Hayato Yamahata,&nbsp;Buntou Ro,&nbsp;Takakazu Kawamata","doi":"10.2176/jns-nmc.2022-0316","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0316","url":null,"abstract":"<p><p>PulseRider (Cerenovus, Irvine, CA, USA) is a relatively novel device used for the treatment of wide-neck aneurysms with a coil-assisted effect. However, treatment options for recurrent aneurysms after PulseRider-assisted coil embolization remain controversial. Here we report a case of recurrent basilar tip aneurysm (BTA) treated with Enterprise 2 after PulseRider-assisted coil embolization. A woman in her 70s underwent coil embolization for a subarachnoid hemorrhage with ruptured BTA 16 years ago. Recurrence was detected at 6-year follow-up, and an additional coil embolization was performed. Nevertheless, gradual recurrence still occurred, and PulseRider-assisted coil embolization was performed without any complications 9 years after the second treatment. However, recurrence was detected once more at 6-month follow-up. Thus, stent-assisted coil embolization using Enterprise 2 (Cerenovus) through PulseRider was selected for angular remodeling. Enterprise 2 was deployed between the right P2 segment of the posterior cerebral artery (PCA) and basilar artery (BA) after an effective coil embolization, which achieved effective angular remodeling between the right PCA and BA. The patient's postoperative course was uneventful, and no recanalization was detected after half a year. Although PulseRider is effective for wide-neck aneurysm treatment, recurrence remains a possibility. Additional treatment using Enterprise 2 is safe and effective with the expectation of angular remodeling.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"115-119"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/27/2188-4226-10-0115.PMC10185358.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9480095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biopsy-proven Primary CNS Lymphoma in the Medulla Oblongata Presenting as Anorexia. 延髓活检证实原发性中枢神经系统淋巴瘤表现为厌食症。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0399
Takaharu Kawajiri, Hayato Takeuchi, Yoshinobu Takahashi, Yuji Shimura, Junya Kuroda, Naoya Hashimoto

Eating disorders caused by brain tumors are infrequently seen. Recent studies revealed that a neurocircuit from the nucleus tractus solitarius of the medulla oblongata to the hypothalamus participates in the control of appetite. Among brain tumors, those located in the brain stem, especially a solitary one in the medulla oblongata, are rare. Tumors in the brainstem are generally considered gliomas, and with the difficulty in reaching the lesion, treatment without histological confirmation is often performed. However, there are a few reported cases of medulla oblongata tumors other than gliomas. We describe a case of a 56-year-old man who presented with persistent anorexia. Magnetic resonance images revealed a solitary tumor in the medulla oblongata. After several examinations, craniotomy for the biopsy of the tumor using the cerebellomedullary fissure approach was carried out and primary central nervous system lymphoma (PCNSL) was histologically proven. The patient was treated with effective adjuvant therapy and was discharged home after he recovered from the symptoms. No tumor recurrence was recognized 24 months after surgery. A PCNSL arising only from the medulla oblongata is very rare, and anorexia can be an initial symptom of a tumor in the medulla oblongata. Surgical intervention is safely achieved and is a key to a better clinical outcome.

脑肿瘤引起的饮食失调并不常见。最近的研究表明,从延髓的孤束核到下丘脑的神经回路参与食欲的控制。在脑肿瘤中,位于脑干的肿瘤,特别是位于延髓的单发肿瘤是罕见的。脑干肿瘤通常被认为是神经胶质瘤,由于难以到达病变部位,通常在没有组织学证实的情况下进行治疗。然而,除了神经胶质瘤外,有少数报道的延髓肿瘤。我们描述了一个56岁的男子谁提出了持续厌食症的情况。磁共振影像显示延髓内一孤立肿瘤。经过多次检查,采用小脑髓裂入路开颅活检肿瘤,组织学证实原发性中枢神经系统淋巴瘤(PCNSL)。患者接受了有效的辅助治疗,症状恢复后出院回家。术后24个月未见肿瘤复发。仅由延髓引起的PCNSL非常罕见,而厌食症可能是延髓肿瘤的初始症状。手术干预是安全的,是获得更好临床结果的关键。
{"title":"Biopsy-proven Primary CNS Lymphoma in the Medulla Oblongata Presenting as Anorexia.","authors":"Takaharu Kawajiri,&nbsp;Hayato Takeuchi,&nbsp;Yoshinobu Takahashi,&nbsp;Yuji Shimura,&nbsp;Junya Kuroda,&nbsp;Naoya Hashimoto","doi":"10.2176/jns-nmc.2022-0399","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0399","url":null,"abstract":"<p><p>Eating disorders caused by brain tumors are infrequently seen. Recent studies revealed that a neurocircuit from the nucleus tractus solitarius of the medulla oblongata to the hypothalamus participates in the control of appetite. Among brain tumors, those located in the brain stem, especially a solitary one in the medulla oblongata, are rare. Tumors in the brainstem are generally considered gliomas, and with the difficulty in reaching the lesion, treatment without histological confirmation is often performed. However, there are a few reported cases of medulla oblongata tumors other than gliomas. We describe a case of a 56-year-old man who presented with persistent anorexia. Magnetic resonance images revealed a solitary tumor in the medulla oblongata. After several examinations, craniotomy for the biopsy of the tumor using the cerebellomedullary fissure approach was carried out and primary central nervous system lymphoma (PCNSL) was histologically proven. The patient was treated with effective adjuvant therapy and was discharged home after he recovered from the symptoms. No tumor recurrence was recognized 24 months after surgery. A PCNSL arising only from the medulla oblongata is very rare, and anorexia can be an initial symptom of a tumor in the medulla oblongata. Surgical intervention is safely achieved and is a key to a better clinical outcome.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"131-137"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/80/2188-4226-10-0131.PMC10247218.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9965004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult Infratentorial Pial Arteriovenous Fistula Treated with Detachable Coils: A Case Report and a Review of Literature. 可拆卸线圈治疗成人幕下动静脉瘘1例报告及文献复习。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0391
Naoya Kidani, Yusuke Inoue, Shohei Nishigaki, Juntaro Fujita, Yuta Sotome, Yusuke Tomita, Kenichiro Muraoka, Nobuyuki Hirotsune, Shigeki Nishino

An appropriate therapeutic option for pial arteriovenous fistula (PAVF) can vary according to the angioarchtecture of the lesion. We present a case of adult infratentorial PAVF treated by transarterial coil embolization. A 26-year-old man was referred to our institution for an asymptomatic intracranial vascular lesion. Cerebral angiograms revealed PAVF fed by three arteries in the right cerebellomedullary cistern. The feeding arteries were accurately identified by three-dimensional rotational angiography and were successfully embolized using coils while normal arterial flow was preserved. This case report suggests that stepwise transarterial coil embolization can cure PAVF under detailed evaluation of its angioarchitecture.

颅底动静脉瘘(PAVF)的适当治疗方案可根据病变的血管结构而有所不同。我们报告一例经动脉线圈栓塞治疗的成人幕下PAVF。一名26岁男子因无症状颅内血管病变被转介至我院。脑血管造影显示右小脑髓池三条动脉供血的PAVF。通过三维旋转血管造影准确识别供血动脉,并在保持正常动脉血流的情况下成功地使用线圈栓塞。本病例报告表明,在详细评估其血管结构的情况下,逐步经动脉线圈栓塞可以治愈PAVF。
{"title":"Adult Infratentorial Pial Arteriovenous Fistula Treated with Detachable Coils: A Case Report and a Review of Literature.","authors":"Naoya Kidani,&nbsp;Yusuke Inoue,&nbsp;Shohei Nishigaki,&nbsp;Juntaro Fujita,&nbsp;Yuta Sotome,&nbsp;Yusuke Tomita,&nbsp;Kenichiro Muraoka,&nbsp;Nobuyuki Hirotsune,&nbsp;Shigeki Nishino","doi":"10.2176/jns-nmc.2022-0391","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0391","url":null,"abstract":"<p><p>An appropriate therapeutic option for pial arteriovenous fistula (PAVF) can vary according to the angioarchtecture of the lesion. We present a case of adult infratentorial PAVF treated by transarterial coil embolization. A 26-year-old man was referred to our institution for an asymptomatic intracranial vascular lesion. Cerebral angiograms revealed PAVF fed by three arteries in the right cerebellomedullary cistern. The feeding arteries were accurately identified by three-dimensional rotational angiography and were successfully embolized using coils while normal arterial flow was preserved. This case report suggests that stepwise transarterial coil embolization can cure PAVF under detailed evaluation of its angioarchitecture.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"145-150"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/51/2188-4226-10-0145.PMC10247219.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9965010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Acquired Factor XIII Deficiency with Systemic Lupus Erythematosus Diagnosed after Repeated Intracerebral Hemorrhages. 反复脑出血后诊断为系统性红斑狼疮的获得性因子13缺乏1例。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0373
Eitaro Okumura, Hiroyuki Onuki, Kunitoshi Otsuka, Shigeki Sunaga, Asashi Tanaka, Hiroyuki Jimbo

We present a case of autoimmune-acquired factor XIII deficiency associated with systemic lupus erythematosus, which was diagnosed as a cause of repeated intracerebral hemorrhage. An intracerebral hemorrhage occurred in a 24-year-old female patient. Craniotomy was performed to remove the hematoma, but rebleeding occurred at the same site on days 2 and 11, respectively. Detailed blood tests revealed that factor XIII activity decreased. Although autoimmune-acquired factor XIII deficiency is a very rare disease, it can sometimes be fatal when intracerebral hemorrhage occurs. If there is repeated intracerebral hemorrhage, factor XIII activity should be confirmed.

我们报告一例自身免疫获得性因子XIII缺乏与系统性红斑狼疮相关,被诊断为反复脑出血的原因。24岁女性患者发生脑出血。开颅切除血肿,但分别于第2天和第11天在同一部位再次出血。详细的血液检查显示十三因子活性下降。虽然自身免疫获得性因子XIII缺乏症是一种非常罕见的疾病,但当发生脑出血时,有时可能是致命的。如果反复出现脑出血,应确认因子XIII的活性。
{"title":"A Case of Acquired Factor XIII Deficiency with Systemic Lupus Erythematosus Diagnosed after Repeated Intracerebral Hemorrhages.","authors":"Eitaro Okumura,&nbsp;Hiroyuki Onuki,&nbsp;Kunitoshi Otsuka,&nbsp;Shigeki Sunaga,&nbsp;Asashi Tanaka,&nbsp;Hiroyuki Jimbo","doi":"10.2176/jns-nmc.2022-0373","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0373","url":null,"abstract":"<p><p>We present a case of autoimmune-acquired factor XIII deficiency associated with systemic lupus erythematosus, which was diagnosed as a cause of repeated intracerebral hemorrhage. An intracerebral hemorrhage occurred in a 24-year-old female patient. Craniotomy was performed to remove the hematoma, but rebleeding occurred at the same site on days 2 and 11, respectively. Detailed blood tests revealed that factor XIII activity decreased. Although autoimmune-acquired factor XIII deficiency is a very rare disease, it can sometimes be fatal when intracerebral hemorrhage occurs. If there is repeated intracerebral hemorrhage, factor XIII activity should be confirmed.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"121-124"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/b5/2188-4226-10-0121.PMC10247216.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9982450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Aneurysmal Subarachnoid Hemorrhage and Epistaxis in an Untreated Prolactinoma: A Case Report and Literature Review. 未经治疗的催乳素瘤并发动脉瘤性蛛网膜下腔出血和鼻出血1例报告并文献复习。
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0355
Masahiro Nishihori, Takashi Izumi, Kazuhito Takeuchi, Shunsaku Goto, Fumiaki Kanamori, Kenji Uda, Kinya Yokoyama, Yoshio Araki, Ryuta Saito

A 61-year-old man presented with massive epistaxis, amaurosis, nausea, and severe headache. A detailed examination revealed a subarachnoid hemorrhage and prolactinoma. Angiography showed a small internal carotid artery pseudoaneurysm and inadequate collateral circulation; thus, uncomplicated coil embolization was performed. Considering the side effects of medication, such as cerebrospinal fluid rhinorrhea, the patient was followed up for asymptomatic prolactinoma without medication after discharge. At 40 months later, aneurysm recurrence was confirmed. Flow diverter device placement was performed, and the outcomes were excellent. In the present report, we described a rare case of a ruptured internal carotid artery aneurysm in an untreated prolactinoma and discussed the literature.

一个61岁的男人提出大量的鼻出血,黑蒙,恶心,和严重的头痛。详细检查显示蛛网膜下腔出血和泌乳素瘤。血管造影显示颈内动脉假性动脉瘤小,侧枝循环不足;因此,进行了简单的线圈栓塞。考虑到药物的副作用,如脑脊液鼻漏,出院后随访无症状催乳素瘤,无需药物治疗。40个月后,确认动脉瘤复发。进行了分流器放置,结果非常好。在本报告中,我们描述了一个罕见的病例破裂的颈内动脉瘤在未经治疗的催乳素瘤,并讨论了文献。
{"title":"Simultaneous Aneurysmal Subarachnoid Hemorrhage and Epistaxis in an Untreated Prolactinoma: A Case Report and Literature Review.","authors":"Masahiro Nishihori,&nbsp;Takashi Izumi,&nbsp;Kazuhito Takeuchi,&nbsp;Shunsaku Goto,&nbsp;Fumiaki Kanamori,&nbsp;Kenji Uda,&nbsp;Kinya Yokoyama,&nbsp;Yoshio Araki,&nbsp;Ryuta Saito","doi":"10.2176/jns-nmc.2022-0355","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0355","url":null,"abstract":"<p><p>A 61-year-old man presented with massive epistaxis, amaurosis, nausea, and severe headache. A detailed examination revealed a subarachnoid hemorrhage and prolactinoma. Angiography showed a small internal carotid artery pseudoaneurysm and inadequate collateral circulation; thus, uncomplicated coil embolization was performed. Considering the side effects of medication, such as cerebrospinal fluid rhinorrhea, the patient was followed up for asymptomatic prolactinoma without medication after discharge. At 40 months later, aneurysm recurrence was confirmed. Flow diverter device placement was performed, and the outcomes were excellent. In the present report, we described a rare case of a ruptured internal carotid artery aneurysm in an untreated prolactinoma and discussed the literature.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"163-168"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/d6/2188-4226-10-0163.PMC10310351.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease. Pit-1/ sf -1阳性双垂体腺瘤与颅咽管瘤合并Graves病的碰撞瘤
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0396
Haruhiko Kikuta, Shinya Jinguji, Taku Sato, Mudathir Bakhit, Ryo Hiruta, Yusuke Sato, Rei Sekine, Hayato Tanabe, Masayasu Okada, Kiyoshi Saito, Masazumi Fujii

Double or multiple pituitary adenomas expressing different types of transcription factors and collision tumors of pituitary adenomas and craniopharyngiomas are rare. In this report, we present a case of pituitary adenoma of two different cell populations, Pit-1 and SF-1, and an adenoma and craniopharyngioma collision tumor with coexisting Graves' disease. The patient had a 16-mm pituitary tumor with pituitary stalk calcification and optic chiasm compression but no visual dysfunction. Based on hormonal profile results, the tumor in the sella was considered a nonfunctioning pituitary adenoma; nevertheless, the pituitary stalk was invaded by a different lesion, which was later confirmed to be a craniopharyngioma. Using an endoscopic endonasal approach, the pituitary adenoma was removed; however, a small remnant remained medial to the right cavernous sinus. Because the pituitary stalk lesion was isolated from the pituitary adenoma, it was preserved to maintain pituitary function. Three years after the initial surgery, the patient suffered from Graves' disease and was treated with antithyroid medications. However, the intrasellar residual and pituitary stalk lesions gradually increased in size. A second surgery was performed, and the residual intrasellar and stalk lesions were completely removed. As per the initial and second histopathologies, the pituitary adenoma comprised different cell groups positive for thyroid-(TSH) and follicle-stimulating hormones, and each cell group was positive for Pit-1 and SF-1. The pituitary stalk lesion was an adamantinomatous craniopharyngioma. We believe that TSH-producing adenoma was involved in the development of Graves' disease or that treatment for Graves' disease increased TSH-producing adenoma.

双或多发表达不同类型转录因子的垂体腺瘤以及垂体腺瘤与颅咽管瘤的碰撞瘤是罕见的。在本报告中,我们报告了一个垂体腺瘤的两个不同的细胞群,Pit-1和SF-1,以及一个腺瘤和颅咽管瘤碰撞肿瘤共存的Graves病。患者垂体瘤长16毫米,垂体柄钙化,视交叉受压,无视力障碍。基于激素谱结果,鞍区肿瘤被认为是无功能垂体腺瘤;然而,垂体柄被不同的病变侵入,后来证实为颅咽管瘤。经鼻内镜入路切除垂体腺瘤;然而,右侧海绵窦内侧仍有一小块残余。由于垂体柄病变与垂体腺瘤分离,因此保存以维持垂体功能。初次手术三年后,患者患上了格雷夫斯病,并接受了抗甲状腺药物治疗。然而,鞍内残余和垂体柄病变逐渐增大。第二次手术进行,残余的鞍内和茎病变被完全切除。根据最初和第二次组织病理学,垂体腺瘤由不同的细胞组组成,这些细胞组对甲状腺激素(TSH)和促卵泡激素呈阳性,每个细胞组对Pit-1和SF-1呈阳性。垂体柄病变为硬瘤性颅咽管瘤。我们认为产生tsh的腺瘤参与了Graves病的发展,或者Graves病的治疗增加了产生tsh的腺瘤。
{"title":"A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease.","authors":"Haruhiko Kikuta,&nbsp;Shinya Jinguji,&nbsp;Taku Sato,&nbsp;Mudathir Bakhit,&nbsp;Ryo Hiruta,&nbsp;Yusuke Sato,&nbsp;Rei Sekine,&nbsp;Hayato Tanabe,&nbsp;Masayasu Okada,&nbsp;Kiyoshi Saito,&nbsp;Masazumi Fujii","doi":"10.2176/jns-nmc.2022-0396","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0396","url":null,"abstract":"<p><p>Double or multiple pituitary adenomas expressing different types of transcription factors and collision tumors of pituitary adenomas and craniopharyngiomas are rare. In this report, we present a case of pituitary adenoma of two different cell populations, Pit-1 and SF-1, and an adenoma and craniopharyngioma collision tumor with coexisting Graves' disease. The patient had a 16-mm pituitary tumor with pituitary stalk calcification and optic chiasm compression but no visual dysfunction. Based on hormonal profile results, the tumor in the sella was considered a nonfunctioning pituitary adenoma; nevertheless, the pituitary stalk was invaded by a different lesion, which was later confirmed to be a craniopharyngioma. Using an endoscopic endonasal approach, the pituitary adenoma was removed; however, a small remnant remained medial to the right cavernous sinus. Because the pituitary stalk lesion was isolated from the pituitary adenoma, it was preserved to maintain pituitary function. Three years after the initial surgery, the patient suffered from Graves' disease and was treated with antithyroid medications. However, the intrasellar residual and pituitary stalk lesions gradually increased in size. A second surgery was performed, and the residual intrasellar and stalk lesions were completely removed. As per the initial and second histopathologies, the pituitary adenoma comprised different cell groups positive for thyroid-(TSH) and follicle-stimulating hormones, and each cell group was positive for Pit-1 and SF-1. The pituitary stalk lesion was an adamantinomatous craniopharyngioma. We believe that TSH-producing adenoma was involved in the development of Graves' disease or that treatment for Graves' disease increased TSH-producing adenoma.</p>","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"169-175"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/7a/2188-4226-10-0169.PMC10310352.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relief of Central Poststroke Pain Affecting Both the Arm and Leg on One Side by Double-independent Dual-lead Spinal Cord Stimulation Using Fast-acting Subperception Therapy Stimulation: A Case Report. 双独立双导联脊髓快速亚知觉治疗缓解单侧手臂和腿部中枢性脑卒中后疼痛1例
Pub Date : 2023-01-01 DOI: 10.2176/jns-nmc.2022-0336
Takafumi Tanei, Satoshi Maesawa, Yusuke Nishimura, Yoshitaka Nagashima, Tomotaka Ishizaki, Manabu Mutoh, Yoshiki Ito, Ryuta Saito
Central poststroke pain is a chronic, intractable, central neuropathic pain. Spinal cord stimulation is a neuromodulation therapy for chronic neuropathic pain. The conventional stimulation method induces a sense of paresthesia. Fast-acting subperception therapy is one of the latest new stimulation methods without paresthesia. A case of achieving pain relief of central poststroke pain affecting both the arm and leg on one side by double-independent dual-lead spinal cord stimulation using fast-acting subperception therapy stimulation is presented. A 67-year-old woman had central poststroke pain due to a right thalamic hemorrhage. The numerical rating scale scores of the left arm and leg were 6 and 7, respectively. Using dual-lead stimulation at the Th 9-11 levels, a spinal cord stimulation trial was performed. Fast-acting subperception therapy stimulation achieved pain reduction in the left leg from 7 to 3. Therefore, a pulse generator was implanted, and the pain relief continued for 6 months. Then, two additional leads were implanted at the C 3-5 levels, and pain in the arm decreased from 6 to 4. Independent setting and adjustments of the dual-lead stimulation were required because the thresholds of paresthesia perception were significantly different. To achieve pain relief in both the arm and leg, double-independent dual-lead stimulation placed at cervical and thoracic levels is an effective treatment. Fast-acting subperception therapy stimulation may be effective for central poststroke pain, especially in cases where the paresthesia is perceived as uncomfortable or the conventional stimulation itself is ineffective.
中枢性脑卒中后疼痛是一种慢性、难治性中枢神经性疼痛。脊髓刺激是一种治疗慢性神经性疼痛的神经调节疗法。传统的刺激方法会引起感觉异常。速效亚知觉治疗是一种新的无感觉异常的刺激方法。本文报道了一种采用双独立双导脊髓快速亚知觉治疗刺激的方法,实现单侧手臂和腿部中枢性脑卒中后疼痛缓解的病例。一位67岁的女性因右丘脑出血而出现中枢性中风后疼痛。左臂和左腿的数值评定量表得分分别为6分和7分。采用双导联刺激th9 -11水平,进行脊髓刺激试验。速效亚知觉治疗刺激使左腿疼痛从7减轻到3。因此,植入脉冲发生器,疼痛缓解持续6个月。然后,在c3 -5水平植入两个额外的导线,手臂疼痛从6减少到4。双导联刺激需要独立设置和调整,因为感觉异常知觉阈值有显著差异。为了缓解手臂和腿部的疼痛,在颈椎和胸椎水平放置双独立双导联刺激是一种有效的治疗方法。速效亚知觉治疗刺激可能对中枢性卒中后疼痛有效,特别是在感觉异常被认为不舒服或常规刺激本身无效的情况下。
{"title":"Relief of Central Poststroke Pain Affecting Both the Arm and Leg on One Side by Double-independent Dual-lead Spinal Cord Stimulation Using Fast-acting Subperception Therapy Stimulation: A Case Report.","authors":"Takafumi Tanei,&nbsp;Satoshi Maesawa,&nbsp;Yusuke Nishimura,&nbsp;Yoshitaka Nagashima,&nbsp;Tomotaka Ishizaki,&nbsp;Manabu Mutoh,&nbsp;Yoshiki Ito,&nbsp;Ryuta Saito","doi":"10.2176/jns-nmc.2022-0336","DOIUrl":"https://doi.org/10.2176/jns-nmc.2022-0336","url":null,"abstract":"Central poststroke pain is a chronic, intractable, central neuropathic pain. Spinal cord stimulation is a neuromodulation therapy for chronic neuropathic pain. The conventional stimulation method induces a sense of paresthesia. Fast-acting subperception therapy is one of the latest new stimulation methods without paresthesia. A case of achieving pain relief of central poststroke pain affecting both the arm and leg on one side by double-independent dual-lead spinal cord stimulation using fast-acting subperception therapy stimulation is presented. A 67-year-old woman had central poststroke pain due to a right thalamic hemorrhage. The numerical rating scale scores of the left arm and leg were 6 and 7, respectively. Using dual-lead stimulation at the Th 9-11 levels, a spinal cord stimulation trial was performed. Fast-acting subperception therapy stimulation achieved pain reduction in the left leg from 7 to 3. Therefore, a pulse generator was implanted, and the pain relief continued for 6 months. Then, two additional leads were implanted at the C 3-5 levels, and pain in the arm decreased from 6 to 4. Independent setting and adjustments of the dual-lead stimulation were required because the thresholds of paresthesia perception were significantly different. To achieve pain relief in both the arm and leg, double-independent dual-lead stimulation placed at cervical and thoracic levels is an effective treatment. Fast-acting subperception therapy stimulation may be effective for central poststroke pain, especially in cases where the paresthesia is perceived as uncomfortable or the conventional stimulation itself is ineffective.","PeriodicalId":19260,"journal":{"name":"NMC Case Report Journal","volume":"10 ","pages":"15-20"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/9b/2188-4226-10-0015.PMC9981231.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10848404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
NMC Case Report Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1